AVASTIN for Cervix carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where AVASTIN was used for Cervix carcinoma.
Most Reported Side Effects for AVASTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 364 | 21.8% | 364 | 11 |
| Disease progression | 255 | 15.3% | 98 | 33 |
| Off label use | 158 | 9.5% | 45 | 21 |
| Fatigue | 78 | 4.7% | 25 | 14 |
| Nausea | 75 | 4.5% | 20 | 26 |
| Hypertension | 70 | 4.2% | 12 | 18 |
| Visual acuity reduced | 64 | 3.8% | 0 | 10 |
| Diarrhoea | 63 | 3.8% | 15 | 23 |
| Vision blurred | 54 | 3.2% | 1 | 6 |
| Drug ineffective | 52 | 3.1% | 18 | 6 |
| Headache | 51 | 3.1% | 4 | 18 |
| Pain | 46 | 2.8% | 12 | 12 |
| Vomiting | 45 | 2.7% | 12 | 18 |
| Dyspnoea | 43 | 2.6% | 8 | 17 |
| Asthenia | 42 | 2.5% | 13 | 16 |
Other Indications for AVASTIN
Product used for unknown indication (292)
Colon cancer (113)
Colorectal cancer (108)
Colorectal cancer metastatic (90)
Ovarian cancer (83)
Glioblastoma (80)
Lung neoplasm malignant (79)
Colon cancer metastatic (70)
Age-related macular degeneration (67)
Breast cancer metastatic (61)
Other Drugs Used for Cervix carcinoma
PACLITAXEL (1,061)
BEVACIZUMAB (1,017)
PEMBROLIZUMAB (791)
CARBOPLATIN (755)
CISPLATIN (685)
TISOTUMAB VEDOTIN-TFTV (163)
ATEZOLIZUMAB (157)
NIVOLUMAB (124)
GEMCITABINE (73)
IPILIMUMAB (66)